Cargando…
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
In breast cancer, inactivating point mutations in the E-cadherin gene are frequently found in invasive lobular carcinoma (ILC) but never in invasive ductal carcinoma (IDC). Lobular carcinoma in situ (LCIS) adjacent to ILC has previously been shown to lack E-cadherin expression, but whether LCIS with...
Autores principales: | Vos, C. B., Cleton-Jansen, A. M., Berx, G., de Leeuw, W. J., ter Haar, N. T., van Roy, F., Cornelisse, C. J., Peterse, J. L., van de Vijver, M. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228132/ https://www.ncbi.nlm.nih.gov/pubmed/9365159 |
Ejemplares similares
-
Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type
por: Vos, C B J, et al.
Publicado: (1999) -
The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression
por: Berx, Geert, et al.
Publicado: (2001) -
E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?
por: Cleton-Jansen, Anne-Marie
Publicado: (2002) -
Genetic alterations in ductal carcinoma in situ and invasive carcinoma of the breast
por: Robanus-Maandag, E, et al.
Publicado: (2000) -
Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene
por: Rahman, N, et al.
Publicado: (2000)